Eyepoint, Inc. · NASDAQ:EYPT

Paradigm Biocapital Advisors LP's stake in Eyepoint, Inc. fell to 3.80% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Paradigm Biocapital Advisors LP's stake in Eyepoint, Inc. fell to 3.80%, 3,142,437 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
3.80%
Shares
3,142,437
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP3.80%3,142,437
Paradigm BioCapital Advisors GP LLC3.80%3,142,437
Senai Asefaw, M.D.3.80%3,142,437
Paradigm BioCapital International Fund Ltd.3.30%2,769,062

Source

View original at SEC

Related